Enliven Therapeutics, Inc. · NASDAQ:ELVN
Polar Capital Holdings Plc's stake in Enliven Therapeutics, Inc. fell to 5.17% (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 14, 2025
Polar Capital Holdings Plc's stake in Enliven Therapeutics, Inc. fell to 5.17%, 2,536,881 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G).
- Stake
- 5.17%
- Shares
- 2,536,881
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Polar Capital Holdings Plc | 5.17% | 2,536,881 |
| Polar Capital LLP | 5.17% | 2,536,881 |
| Polar Capital Funds PLC - Biotechnology Fund | 5.17% | 2,536,881 |
Source
Related
- Enliven Therapeutics, Inc.
- Polar Capital Holdings Plc
- Enliven Therapeutics, Inc. shareholders
- Schedule 13G/A · Polar Capital Holdings Plc · Jun 22, 2026
- Schedule 13G/A · Polar Capital Holdings Plc · May 15, 2026
- Schedule 13G/A · Polar Capital Holdings Plc · May 15, 2026
- Schedule 13G/A · Polar Capital Holdings Plc · Feb 14, 2025
- Form 4 · Hohl Benjamin · Oct 21, 2026
- Form 4 · Collins Helen Louise · Oct 21, 2026
- Form 4 · Garland J. Scott · Oct 5, 2026
- Form 4 · Hohl Benjamin · Sep 21, 2026
- Form 4 · Collins Helen Louise · Sep 21, 2026